Tag | Content |
---|
EnhancerAtlas ID | HS052-24530 | Organism | Homo sapiens | Tissue/cell | Fibroblast_foreskin | Coordinate | chr22:18215620-18216900 | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_09461 | chr22:18214240-18217748 | CD14 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH22I017733 | chr22 | 18216122 | 18218659 |
| Enhancer Sequence | CATTCCTTAA TTAAGGTCAA TTTAGTGTTG GCTCAAATGC TTTCATCTCA AAAATACCGG 60 AATTGAATGG TAATTTGGAT AATTAAGTTA TCGTGCATTT TAAGCAGCAT GTGTTTCCTT 120 TTTCCGTGTG AGTTCCATGA GCCTCTGCAC TGCCGCTCTG CACTGCTGAA CTGATCACTG 180 TGGGTCATTC TGGCTCCTCT TCCTTCCTGT CATCTACCTT TTGGCCAATC TACTCTTCAT 240 CAGGGGAAAG GAACAAACTT CAAATCTGTG AGTTATTCTT TCTGTCAGAA GCAACGTGCT 300 AGAGAGAATA CATGGGATTT GAAGATAATC AGTGGACTCA TCTTTCTATC CACATGGTAA 360 CTATGCCCTT GACAGGTGGT ATCATTTCAC ATCATCAATT GTCTTTGTTA AGTCCATACT 420 TAATTGGTTT GACTCCAGGT TTTGAAAACA AGATCGTAAC ATTCAAAGGA CTCTATATTC 480 CAATTCTCAG CTAGCACAAC TAATAAAGTT GCTGGACAGT AAAACTAGGC GCCAGTGCTG 540 TGATCCTTTA AGGAAGCCTT GAGTATCGCA GCAGTTAATG CTGGGTCCTA AGAGGAGAGG 600 TCAGGAATGA TTTGACCTTC TGAATGCACC AAATGTCCCA CGTGACTTTC AGATACACCA 660 AGCATCTTTT CAAGGAGAAA GCTTTTGATG TTTAACAAAA GAATTTCCAT CACTTAATTC 720 AAATATTTTT AAAACAGAAA GGAAAACACA TTCTCTGAAT TAAAGTCACC TTTGAATCAT 780 ATCCACAAGG ATTGTGTTAC AGGGCAAAAT CCACCAACTG CCAGGATATG CCCGAGTCAC 840 CATGGCTGGG AAGTGCTCAA GACTGGAACA TTTGTGTTTG AGACAATGGA ATCTTTTTAT 900 AATGTTGGCT TTGGGAGAAG GGGTGACGGT CTTGCTTTAC AACCAAGACT ATCTCAGACT 960 TGGTCTGGAA GAATTTACAC TAAGACCTGT TATAAAATGG TGGCCTACTG TATGAATTCA 1020 AGTGAAACAG AAGCAGGTGA AGATGCTGTG GAAGAGTCAG TGTGTGAGAG AGGTGGTCCA 1080 GAGTCACTTG CTGCTTAAGA ACACTTTCCC ATTAGTTCCG GGTGATGACT GCATACAGCT 1140 CCTTTGGGAA GAAAATGCCT CCCCCAGTGA GAATCTGATT ATAATGGCTG ACGTATGGAT 1200 GGATGTGTAG GCGCAGTGTG GTTCAACCTG TTTCCATTGT GGTTGGAAAA CTTTTTTAAA 1260 AGTCCACTCC AAAACATGAA 1280
|
| |
|
|
|